NEW YORK (GenomeWeb News) — US patent regulators have put Applied Biosystems at a big disadvantage in an important sequencing technology issue after they recently named a key licensing partner the junior party in a patent-interference review triggered after a 25-year-old patent application filed by Enzo Biochem was approved.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Penn State Hershey Medical Center staffer has admitted to lying about skipping mandatory steps of genetic cancer tests he performed, the Associated Press reports.

The genome of a rare, red bat suggests that its effective population size has been in decline for thousands of years, according to a PLOS One study.

In Nature this week: investigation into the genetics of medulloblastoma, and more.

A project in the UK is to use genomic selection to speed spruce tree growth, according to Innovators Magazine.